ALFA Finder| Management target | Revenue FY27 |
|---|
| Revenue growth | Revenue surged 106.3% QoQ to 626.9 Cr, driven by ethanol volumes. |
|---|---|
| Margins | EBITDA margin improved to 23.5% via lower cost grain feedstocks. |
| Order book | Firm ethanol orders in hand for 44 crore liters. |
| Demand visibility | Strong visibility from OMC orders and 20% ethanol blending mandate. |
| Management confidence | Highly optimistic on multi-feed pivot but cautious about retail fuel expansion. |
Growth
PAT surged over 1000% YoY to 59.3 Cr, while revenue crossed 625 Cr due to higher plant utilization.
Outlook
Targets 4000 Cr annual revenue at full ethanol utilization; 700 Cr CBG capex to yield revenue by Q4.
Risks
High finance costs (180 Cr annual run-rate) and Middle East geopolitical tension delaying retail expansion plans.
Last quarter's promises, checked
Delivered
- Guided 11 retail outlets in 3 months → delivered 11 (= BEAT)
- Guided 150 Cr PMG1 subsidy approval → delivered 150 Cr (= BEAT)
Partly delivered
- Guided 32 Cr liter volume target → delivered 24 Cr liters (= PARTIAL)
Missed
- Guided 350-400 Cr monthly revenue → delivered 209 Cr (= MISS)
Earnings Call Transcript filed with NSE, NSE: TRUALT. Summary written with AI assistance from the document.
TruAlt Bioenergy Ltd: key numbers
- Share price
- ₹350.00
- Market cap
- ₹3,001 Cr
- Revenue (annual)
- ₹1,728 Cr
- Net profit (annual)
- ₹95.95 Cr
- P/E (TTM)
- 13.6×Sector 29.0×
- Promoter holding
- 71.38%+0.83% QoQ
- FII holding
- 0.62%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from TruAlt Bioenergy Ltd
All →TruAlt Bioenergy Other Announcement
TruAlt Bioenergy filed Crisil's monitoring agency report for the quarter ended 30 September 2026 on its Rs 750 crore IPO proceeds. The report notes no deviation from the IPO objects.
TruAlt Bioenergy Earnings Call Transcript: Key Takeaways
TruAlt reported massive 606% YoY revenue growth, turning profitable despite raw material price surges. Management is pivoting from ethanol to high-margin CBG to insulate from feedstock volatility.
TruAlt Bioenergy Investor Presentation: Key Takeaways
Q2 FY27 consolidated total income ₹823.74 Cr, PAT ₹34.99 Cr, EBITDA margin 12.47%. H1 PAT ₹94.27 Cr, EBITDA ₹233.92 Cr (16.27% margin). Strategy: integrated bioenergy across ethanol, CBG, SAF, retail.
TruAlt Bioenergy Results Update
TruAlt Bioenergy reported H1 FY27 revenue of ₹1,437.98 crore, EBITDA of ₹233.92 crore and PAT of ₹94.27 crore via press release. Results reverse last year's H1 loss.
TruAlt Bioenergy Q2 FY27 Results: Turns Profitable, Net Profit ₹35 Cr
TruAlt Bioenergy Ltd reported revenue from operations of ₹811.1 Cr (+605.9% YoY) and net profit of ₹35 Cr for Q2 FY27.
- Key figure
- Net profit ₹35 Cr
TruAlt Bioenergy Management Change
Mr. Monu Kumar resigned as Company Secretary and Compliance Officer of TruAlt Bioenergy Limited, effective October 16, 2026, due to personal reasons.